Detalhe da pesquisa
1.
The efficacy of sorafenib against hepatocellular carcinoma is enhanced by 5-aza-mediated inhibition of ID1 promoter methylation.
FEBS Open Bio;
14(1): 127-137, 2024 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37964494
2.
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.
Cell Death Dis;
9(9): 852, 2018 08 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30154433